Lorem ipsum dolor sit amet, consectet eiusmod tempor incididunt ut labore e rem ipsum dolor sit amet. sum dolor sit amet, consectet eiusmod.
| Mon - Fri: | 8:00 am - 8:00 pm |
| Saturday: | 9:00 am - 6:00 pm |
| Sunday: | 9:00 am - 6:00 pm |






Optilume® BPH Catheter System for the treatment of Benign Prostatic
Hyperplasia (BPH)
Safe, Effective, and Durable BPH Relief
Introducing the next-generation of minimally invasive BPH treatment. The Optilume BPH Catheter System revolutionizes the treatment paradigm by providing immediate and durable symptom relief for men* experiencing BPH induced lower urinary tract symptoms.
This minimally invasive surgical therapy combines mechanical dilation with concurrent localized delivery of paclitaxel for treating BPH.
Mechanical dilation with the proprietary double-lobe balloon technology
achieves an anterior commissurotomy (split) releasing the constricting lateral lobes, while the delivery of paclitaxel prevents re-fusion of the lobes and maintains patency during healing.
No cutting. No heating. No burning. No lasering. No steaming. No implantation!
Safe
Safety profile in-line with existing BPH MISTs
In the 5-year EVEREST trial and 2-year PINNACLE trial follow-up, there was No impact on erectile and ejaculatory function
Effective
The highest Qmax reported in BPH MIST trials to date
Durable
Clinical results show long-lasting relief.
The PINNACLE randomized control trial shows excellent results through 2-year primary endpoint
follow up and is supported by the EVEREST feasibility study (1) showing sustained improvements up to 5 years (1) and a low pharmacological and surgical retreatment rate.
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.